A prospective comparison between liraglutide-plus-basal-insulin combined therapy and intensive insulin therapy in patients with non-insulin-dependent type2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Liraglutide (Primary) ; Alpha-glucosidase inhibitors; Insulin; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Aug 2018 New trial record